BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rödel F, Martin D, Balermpas P, Wieland U, Winkelmann R, Riekmann T, Falk S, Rödel C, Fokas E. Modulation of radiation sensitivity and antitumor immunity by viral pathogenic factors: Implications for radio-immunotherapy. Biochim Biophys Acta Rev Cancer 2019;1871:126-37. [PMID: 30605716 DOI: 10.1016/j.bbcan.2018.12.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Mkrtchian L, Zamulaeva I, Krikunova L, Kiseleva V, Matchuk O, Liubina L, Kulieva G, Ivanov S, Kaprin A. HPV Status and Individual Characteristics of Human Papillomavirus Infection as Predictors for Clinical Outcome of Locally Advanced Cervical Cancer. J Pers Med 2021;11:479. [PMID: 34071821 DOI: 10.3390/jpm11060479] [Reference Citation Analysis]
2 Fleischmann M, Chatzikonstantinou G, Fokas E, Wichmann J, Christiansen H, Strebhardt K, Rödel C, Tselis N, Rödel F. Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer. Cancers (Basel) 2021;13:5748. [PMID: 34830902 DOI: 10.3390/cancers13225748] [Reference Citation Analysis]
3 Özcan-Wahlbrink M, Schifflers C, Riemer AB. Enhanced Radiation Sensitivity of Human Papillomavirus-Driven Head and Neck Cancer: Focus on Immunological Aspects. Front Immunol 2019;10:2831. [PMID: 31849993 DOI: 10.3389/fimmu.2019.02831] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
4 Gaipl US, Multhoff G, Pockley AG, Rödel F. Editorial: Radioimmunotherapy-Translational Opportunities and Challenges. Front Oncol 2020;10:190. [PMID: 32154180 DOI: 10.3389/fonc.2020.00190] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Gupta I, Ghabreau L, Al-Thawadi H, Yasmeen A, Vranic S, Al Moustafa AE, Malki MI. Co-incidence of Human Papillomaviruses and Epstein-Barr Virus Is Associated With High to Intermediate Tumor Grade in Human Head and Neck Cancer in Syria. Front Oncol 2020;10:1016. [PMID: 32974123 DOI: 10.3389/fonc.2020.01016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wedekind H, Walz K, Buchbender M, Rieckmann T, Strasser E, Grottker F, Fietkau R, Frey B, Gaipl US, Rückert M. Head and neck tumor cells treated with hypofractionated irradiation die via apoptosis and are better taken up by M1-like macrophages. Strahlenther Onkol 2021. [PMID: 34665291 DOI: 10.1007/s00066-021-01856-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wurlitzer M, Möckelmann N, Kriegs M, Vens M, Omidi M, Hoffer K, Bargen CV, Möller-Koop C, Witt M, Droste C, Oetting A, Petersen H, Busch CJ, Münscher A, Schlüter H, Clauditz TS, Rieckmann T. Mass Spectrometric Comparison of HPV-Positive and HPV-Negative Oropharyngeal Cancer. Cancers (Basel) 2020;12:E1531. [PMID: 32545200 DOI: 10.3390/cancers12061531] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
8 Fleischmann M, Glatzer M, Rödel C, Tselis N. Radioimmunotherapy: future prospects from the perspective of brachytherapy. J Contemp Brachytherapy 2021;13:458-67. [PMID: 34484362 DOI: 10.5114/jcb.2021.108601] [Reference Citation Analysis]